• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

CloSys Corp.

Diabetes device maker Mendor raises $11.7 million | Funding Roundup

July 1, 2011 By MassDevice staff Leave a Comment

Funding

Mendor, a Finish diabetes technologies and services company, raised $11.7 million in a Series B financing round, aiming for global expansion.

Funding was led by Finnish entrepreneur and investor Risto Siilasmaa, joined by Life Sciences Partners (LSP), Finnish Industry Investment Ltd., Finnish Mutual Pension Insurance Company Ilmarinen, private Finnish investment group Biothom and the Finnvera Venture Capital as a returning investor.

Filed Under: Funding Roundup, News Well Tagged With: Biolase, CardioInsight Technologies Inc., CloSys Corp., Digital Assent, Eliza Corp., Impel Neuropharma, integer, LipoScience Inc., Mendor, OrthoCor Medical Inc., Pressure BioSciences Inc., Venture Capital/Private Equity

CloSys closes in on $2.4 million

September 16, 2010 By MedCity News Leave a Comment

MedCity News logo

CloSys Corp. is seeking $2.4 million from an equity offering, according to documents filed with the Securities & Exchange Commission.

The company, based in New Brighton, Minn., already has raised $1.5 million, according to the filing.

Founded in 2005 by chief scientific officer Karol Nowakowski, CloSys is developing a clotting technology designed to quickly seal an artery wall after vascular surgery. The company expects to release results from a pivotal clinical trial in the U.S. by the end of the year.

Filed Under: Business/Financial News, News Well Tagged With: CloSys Corp., Vascular Closure

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS